Varithena (polidocanol injectable foam) is a sclerosant and causes fibrosis inside varicose veins, occluding the lumen of the vessel, and reducing the appearance of the varicosity.
Varithena is specifically indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous vein system above and below the knee.
Submit your review
Adverse effects associated with the use of Varisolve may include, but are not limited to, the following:
pain/discomfort in extremity
infusion site thrombosis (retained coagulum)
injection site hematoma or pain
Varithena is supplied as a foam for intravenous administration. Varithena should be used under ultrasound guidance only. Use up to 5 ml per injection and 15 ml per treatment session . Treatments sessions should be seperated by a minimum of 5 days.